Stock listing
NASDAQ:TSRO Tesaro Inc Stock
Follow Tesaro Inc into a list and get an email when it puts out news.
Last close · NASDAQ:TSRO
$74.96 USD
Close on Jan 18, 2019 · No longer trades
- Lowest – highest close
- $11.25 – $190.36 USDSince Jun 28, 2012 · lowest Aug 29, 2012 · highest Feb 17, 2017
Delisted NASDAQ:TSRO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:TSRO
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Tesaro Inc on 6ix
- Decks
- 12 decks · latest Jan 8, 2018
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2018) | Investor deck | 47 slides | Jan 8, 2018 |
| Investor Presentation (March 2016) | Investor deck | 66 slides | Mar 16, 2016 |
| Q4 2015 Earnings Presentation | Earnings | 22 slides | Feb 25, 2016 |
| Conference Call with Clients of Leerink Partners (October 2015) | Conference | 11 slides | Oct 15, 2015 |
| Q3 2014 Earnings Presentation | Earnings | 15 slides | Nov 5, 2014 |
| Q2 2014 Earnings Presentation | Earnings | 17 slides | Jul 24, 2014 |
| Q1 2014 Earnings Presentation | Earnings | 18 slides | Apr 30, 2014 |
| Merger or Acquisition (March 2014) | Merger or acquisition | 20 slides | Mar 13, 2014 |
| Investor Presentation (January 2014) | Investor deck | 27 slides | Jan 8, 2014 |
| Q3 2013 Earnings Presentation | Earnings | 24 slides | Nov 7, 2013 |
All 12 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (February 2013) | Technical | 10 slides | Feb 14, 2013 |
| Investor Presentation (January 2013) | Investor deck | 29 slides | Jan 7, 2013 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Beth C Seidenberg Other companies: Latigo Biotherapeutics, Inc. (Director · Since at least Aug 6, 2026); Kyverna Therapeutics, Inc. (Director · Since at least Feb 7, 2024); Sagimet Biosciences Inc. - Series A (Director · Since at least Jul 13, 2023); Vera Therapeutics, Inc. (Director · Since at least May 13, 2021); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Progyny, Inc. (Director · Oct 24, 2019 – May 23, 2024 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Jun 22, 2018 · Past); Atara Biotherapeutics, Inc. (Director · Oct 15, 2014 – May 31, 2023 · Past); Epizyme Inc (Director · May 30, 2013 – Jun 30, 2019 · Past) | Director · Jun 27, 2012 – Jan 22, 2019 · Past |
| Mary Lynne Hedley Other companies: Eli Lilly and Company (Director · Since at least May 15, 2022); Centessa Pharmaceuticals PLC (Director · Since at least May 27, 2021); Veeva Systems Inc. (Director · Since at least Aug 16, 2019); Tempest Therapeutics, Inc. (Director · Dec 7, 2018 – Jun 22, 2020 · Past); Bluebird bio Inc (Director · Sep 18, 2017 – Jun 20, 2018 · Past); Receptos Inc (Director · Apr 11, 2014 – Aug 27, 2015 · Past); Abraxis BioScience Inc (Executive VP of Ops & CSO · Jul 9, 2009 – Jul 13, 2009 · Past) | President & COO, Director · Jun 27, 2012 – Jan 22, 2019 · Past |
| Arnold L Oronsky Other companies: PMV Pharmaceuticals, Inc. (Director · Sep 24, 2020 – Sep 25, 2020 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 1, 2020 · Past); MacroGenics, Inc. (Director · Oct 9, 2013 – Feb 18, 2014 · Past); Anesiva Inc (Director · Jun 22, 2006 – May 9, 2008 · Past); Myogen Inc (Director · May 4, 2006 – Nov 13, 2006 · Past); Dynavax Technologies Corporation (Director · Feb 23, 2006 – May 28, 2020 · Past) | Director · Jun 27, 2012 – Aug 7, 2018 · Past |
| Richard Rodgers Other companies: Novavax, Inc. (Director · Since at least Oct 29, 2022); Opus Genetics, Inc. (Director · Since at least Dec 2, 2014); Ardelyx, Inc. (Director · Since at least Jun 18, 2014); Sagimet Biosciences Inc. - Series A (Director · Jul 13, 2023 – Jul 18, 2023 · Past); Abraxis BioScience Inc (Senior Vice President and CFO · Jul 9, 2009 – Jul 13, 2009 · Past); Mgi Pharma Inc (Sr. VP and Controller · Jul 15, 2006 – Jan 28, 2008 · Past) | Executive VP & CFO · Jun 27, 2012 – Mar 6, 2013 · Past |
| Lawrence M. Alleva Other companies: Galera Therapeutics, Inc. (Director · Since at least Nov 6, 2019); Mersana Therapeutics Inc (Director · Since at least Sep 5, 2017); Bright Horizons Family Solutions Inc. (Board Member · Since at least May 12, 2016); Adaptimmune Therapeutics PLC (Chairman and Non-Executive Director · Since at least Jan 1, 2016); Synlogic Inc (Director · Sep 30, 2015 – Jun 29, 2016 · Past) | Director · Jun 1, 2016 – Jan 22, 2019 · Past |
| Leon O Moulder Jr Other companies: Zenas BioPharma, Inc. (See Remarks, Director · Since at least Sep 12, 2024); Zai Lab Ltd. (Director · Since at least Jan 1, 2021); Dianthus Therapeutics, Inc. (Director · Sep 11, 2023 – May 23, 2024 · Past); Trevena, Inc. (Director · May 16, 2018 – Jun 15, 2023 · Past) | Chief Executive Officer, Director · Mar 1, 2018 – Jan 22, 2019 · Past |
| Timothy R. Pearson Other companies: Korro Bio, Inc. (Director · Since at least Nov 3, 2023); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past); Crescent Biopharma, Inc. (Director · Mar 31, 2014 – May 1, 2024 · Past); Catalyst Health Solutions Inc (EVP & Chief Financial Officer · Aug 22, 2011 – Jul 2, 2012 · Past) | Exec. VP, CFO · May 27, 2014 – Jan 22, 2019 · Past |
| Jack A Khattar Other companies: Cognition Therapeutics, Inc. (Director · Since at least Oct 7, 2021); Scpharmaceuticals Inc (Director · Since at least Nov 16, 2017); Supernus Pharmaceuticals, Inc. (President, CEO, Director · Since at least Apr 30, 2012) | President, CEO, Director · Mar 29, 2016 – Mar 29, 2016 · Past |
| Pascale Witz Other companies: Revvity, Inc. (Director · Since at least Oct 27, 2017); Regulus Therapeutics Inc (Director · Since at least Jun 1, 2017); Horizon Pharma PLC (Director · Aug 2, 2017 – Aug 2, 2018 · Past) | Director · May 10, 2018 – Jan 22, 2019 · Past |
| Grant Bogle Other companies: Nuvalent, Inc. (Director · Since at least Dec 5, 2024); Epizyme Inc (President and CEO, Director · Sep 2, 2019 – Aug 12, 2022 · Past) | Sr. VP, Chief Commercial Ofc · Jul 13, 2015 – Jan 22, 2019 · Past |
All 11 people
| Person | Seat |
|---|---|
| Jeffrey H Hanke | Executive VP, R&D and CSO · Jun 29, 2015 – Aug 30, 2016 · Past |
Log in to ask 6ix AI your own questions about Tesaro Inc.